Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Aberg

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
AIDS Clinical Review|September 22, 2000
Reconstitution of immunity against opportunistic infections in the era of potent antiretroviral therapyJ A Aberg
AIDS Clinical Review|January 1, 1997
Cryptococcal disease: implications of recent clinical trials on treatment and managementJ A Aberg, W G Powderly
Cleveland Clinic Journal of Medicine|May 1, 1996
Idiopathic hypoparathyroidism in a blind, deaf, elderly woman with dementiaJ A Aberg, M J Gorbien
The AIDS Reader|June 8, 2001
HIV and cardiovascular risk factorsO M Falusi, J A Aberg
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
CryptococcosisJ A Aberg, W G Powderly
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2014
Reply to Monroe and BrownA Danoff, M Horberg, J A Aberg
Chest|March 20, 1999
Pulmonary cryptococcosis in patients without HIV infectionJ A Aberg, L M Mundy, W G Powderly
Archives of Neurology|April 1, 1993
Immunoglobulin G immunosuppression of multiple sclerosis. Suppression of all three major lymphocyte subsetsR B Tenser, K A Hay, J A Aberg
The Journal of Infectious Diseases|October 21, 1998
Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapyJ A Aberg, D M Yajko, M A Jacobson
HIV Clinical Trials|October 9, 2001
Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS-related cryptococcal diseaseJ A Aberg, J Watson, M Segal, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
AIDS Clinical Review|September 22, 2000
Reconstitution of immunity against opportunistic infections in the era of potent antiretroviral therapyJ A Aberg
AIDS Clinical Review|January 1, 1997
Cryptococcal disease: implications of recent clinical trials on treatment and managementJ A Aberg, W G Powderly
Cleveland Clinic Journal of Medicine|May 1, 1996
Idiopathic hypoparathyroidism in a blind, deaf, elderly woman with dementiaJ A Aberg, M J Gorbien
The AIDS Reader|June 8, 2001
HIV and cardiovascular risk factorsO M Falusi, J A Aberg
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
CryptococcosisJ A Aberg, W G Powderly
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2014
Reply to Monroe and BrownA Danoff, M Horberg, J A Aberg
Chest|March 20, 1999
Pulmonary cryptococcosis in patients without HIV infectionJ A Aberg, L M Mundy, W G Powderly
Archives of Neurology|April 1, 1993
Immunoglobulin G immunosuppression of multiple sclerosis. Suppression of all three major lymphocyte subsetsR B Tenser, K A Hay, J A Aberg
The Journal of Infectious Diseases|October 21, 1998
Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapyJ A Aberg, D M Yajko, M A Jacobson
HIV Clinical Trials|October 9, 2001
Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS-related cryptococcal diseaseJ A Aberg, J Watson, M Segal, et al.
Pageof 2